NCT03121482View on ClinicalTrials.gov

High-flow Nasal Cannula Oxygen Therapy With or Without NIV During the Weaning Period

NACompletedINTERVENTIONAL
Enrollment

650

Participants

Timeline

Start Date

April 20, 2017

Primary Completion Date

April 17, 2018

Study Completion Date

April 17, 2018

Conditions
Acute Respiratory Failure Requiring Reintubation
Interventions
DEVICE

HFNC

Gas flow of 50 l/min and FiO2 adjusted to obtain SpO2 ≥ 92%

DEVICE

NIV

Pressure-support level to achieve an expired tidal volume between 6 and 8 ml/kg and PEEP level of 5 cm H2O with FiO2 adjusted to obtain SpO2 ≥ 92%

Trial Locations (1)

86000

CHU Poitiers, Poitiers

All Listed Sponsors
lead

Poitiers University Hospital

OTHER

NCT03121482 - High-flow Nasal Cannula Oxygen Therapy With or Without NIV During the Weaning Period | Biotech Hunter | Biotech Hunter